Clinical Trial Monitoring with Precision

Navigating the path to Precision in every study.

At Precision for Medicine, our Clinical Trial Monitoring strategies blend the art of oversight with the capabilities of innovative technologies. With an unwavering commitment to patient safety, data integrity, and trial efficiency, we will enhance each phase of your clinical development journey. We transform challenges into milestones, guiding your journey to success with unmatched precision

Principles of Precision in Clinical Trial Monitoring

At Precision for Medicine, our Clinical Research Associates (CRAs) serve as the linchpin between trials and triumph. Grounded in a philosophy that intertwines the safety of patients with the sanctity of data, our CRAs embody a suite of principles to diligently advance your trial’s objectives. Through proactive site management, effective communication, and unwavering compliance, they ensure each monitored site resonates with the rigor and care that define Precision’s approach to clinical oversight. Our commitment extends beyond standard practices, nurturing a culture of training and mentorship to foster growth and excellence in clinical monitoring.

Patient Safety First

Our CRAs prioritize patient well-being, meticulously monitoring safety protocols and ensuring prompt reporting of adverse events to safeguard participants.
Proactive Site Management

Vigilant and forward-thinking, our CRAs embrace site responsibility, preemptively addressing risks and streamlining solutions for challenges ahead
Effective Communication

Timely dissemination of site updates and swift report filing keep all stakeholders informed and engaged with the latest trial developments.
Compliance & Protocol Adherence

With a rigorous commitment to GCP and regulatory standards, our CRAs ensure protocol fidelity and comprehensive documentation integrity.
Training & Mentorship

We invest in continuous training and mentorship to empower our CRAs with the expertise and confidence to excel in the field.
Data Integrity Focus

The cornerstone of our mission is to safeguard the precision and integrity of study data, fueling reliable outcomes and decisive insights.

Precision in Clinical Monitoring strategies

Precision is adept in the distinct demands of early and late-phase clinical trials, particularly within the realms of Oncology and Rare Disease research. Each phase carries unique monitoring considerations, such as the intensive oversight required during the initial dosing of Phase I studies. Precision tailors monitoring approaches to your trial's design, collaborating with you to determine the monitoring intensity required for optimal data quality and cost-efficiency.

SDV Scenarios
Risk-based Monitoring
Centralized Monitoring

Tailored Source Data Verification Approaches

Precision recognizes that a one-size-fits-all approach does not apply when it comes to Source Data Verification (SDV). Depending on the design and phase of your trial, different SDV strategies—be it 100%, reduced or targeted SDV—can be implemented to maximize data quality while optimizing the allocation of monitoring resources. With our nuanced understanding, we craft SDV monitoring plans that support the depth of data scrutiny required, whether that involves comprehensive verification or a targeted review aligned with specific data risks and study endpoints. By selecting the most suitable SDV method, Precision enhances the integrity of your data and the efficiency of your trial monitoring.
Enhancing Clinical Oversight with Risk-Based Monitoring

At Precision, we embrace a data-centric approach to Risk-Based Monitoring (RBM). By identifying the critical data and how it is collected, we identify potential risks and develop robust strategies to proactively secure the data, enabling our CRAs to focus their efforts where it's most needed. This method not only streamlines the monitoring process but also allocates resources more effectively so that critical trial aspects receive the attention required without undue expenditure. Utilizing advanced analytical tools, such as Precision's Clarity alongside industry-standard platforms like Medidata CTMS, our RBM strategies are designed to safeguard the integrity of your trial data while optimizing the monitoring workload.
Enhanced Centralized Monitoring with Precision

Precision's Centralized Monitoring team leverages our proprietary Clarity clinical intelligence suite to provide a comprehensive review of aggregate data, identifying outliers, trends, and safety signals. Our strategic approach reduces the need for frequent onsite visits by utilizing powerful analytics and dynamic data visualization, augmented by our cross-functional and integrated data review process. This enables Precision to optimize site performance and data integrity, supporting a streamlined SDV/SDR strategy.

Explore

I recognize that relations between Sponsors and CRO vendors can be strained and difficult, often a blaming game; this has never been my experience with this group as it truly felt like a partnership.

— Director, Small Biotech
At so many levels, the Precision for Medicine team has been fantastic. I am very grateful for how responsive and how collaborative the whole team is. Very grateful for their help.

— Director, Midsize Biotech
Precision is part of our team. They put in long days and hard work to help our study to move forward. We are so appreciative of how fast they worked.

— Senior Manager, Clinical Trials, Midsize Biotech
Our partnership with Precision is a true textbook definition of a great collaboration between a sponsor and a CRO.

— Senior Director, Midsize Biotech

Transforming clinical trials through patient centricity

The emphasis on patient centricity and decentralized clinical trials (DCTs) is more than a trend—it’s a transformative shift towards respecting and accommodating the real-world contexts of patients and their caregivers. Precision for Medicine champions this shift, drawing from our rich experience across oncology and rare diseases, to design trials that are as considerate as they are scientifically rigorous. By thoughtfully incorporating patient lifestyles and symptoms into trial designs, we ensure participation is not only viable but also meaningful for patients and caregivers alike. Our strategies embody our commitment to making trials more patient-centric, from pediatric to adult populations, offering a smoother and more inclusive research journey. Discover how our innovative approaches in patient recruitment (HL) and DCTs (HL) are making a difference.

Experts in Complex Diseases and Advanced Therapies

We recognize the patient journey throughout the development process. Our mission is to assist our partners in delivering innovative treatments to patients. Leverage our deep expertise in these therapeutic areas to advance your clinical goals.

Oncology Explore

Rare diseases Explore

Autoimmune Explore

Gene Therapy Explore

Cell Therapy Explore

Precision insights in Clinical Monitoring and beyond

Stay at the forefront of research with Precision’s blog, featuring key updates and insights on clinical monitoring, case studies, and more

Explore Our Blog

Clinical Trials - Early Phase Research - Autoimmune

Case Study: Delivering an Early-Phase Autoimmune Trial Across Regions

Jun 11, ‘26 | 8 min read

has third author: false, (SizeLimitingPyMap: {main={hs_id=214928090133, hs_child_table_id=0, hs_updated_at=1781285625399, hs_published_at=1781285742914, description=Deborah Spencer is a Senior Director of Project Management at Precision for Medicine with over 25 years of experience in clinical research. She specialises in leading global clinical trials across multiple phases, with deep expertise in complex study delivery. Deborah provides strategic oversight of programmes, leads high-performing teams, and partners closely with sponsors to ensure successful execution and regulatory readiness., avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Deborah%20Spencer.jpg',altText='Deborah Spencer',fileId=214838919278}, lastname=Spencer, hs_initial_published_at=1781285742914, hs_created_by_user_id=26433386, hs_created_at=1781285562019, hs_is_edited=false, hs_deleted_at=0, name=Deborah, job=Senior Director, Project Management, slug=deborah-spencer, hs_updated_by_user_id=26433386}, second={hs_id=214928170660, hs_child_table_id=0, hs_updated_at=1781285676367, hs_published_at=1781285742914, description=Anthea Gates is a Project Director with approximately 30 years of drug development and medical device industry expertise across all phases, over a variety of indications including breast, lung cancer, solid tumors and lymphoma, cutaneous T-cell lymphoma, malignant melanoma, squamous cell carcinoma, rare haematologic disease, autoimmune rheumatology, osteoarthritis, ocular burns, liver cirrhosis, myopia and pre-eclampsia.  Committed to delivering quality and passionate about building positive relationships with clients and study teams to promote cohesive business practices and ensure the successful management of projects from start to finish. Anthea holds a proven track record in effective leadership of cross-functional teams across programs of studies, to the accomplishment of operational excellence., avatar=Image{width=372,height=546,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/profile.jpg',altText='profile',fileId=214846873938}, lastname=Gates, hs_initial_published_at=1781285742914, hs_created_by_user_id=26433386, hs_created_at=1781285639221, hs_is_edited=false, hs_deleted_at=0, name=Anthea, job=Project Director, slug=anthea-gates, hs_updated_by_user_id=26433386}, third={hs_id=214928090141, hs_child_table_id=0, hs_updated_at=1781285738567, hs_published_at=1781285742914, description=Claire Delaville is a Senior Project Manager at Precision for Medicine. She brings 18 years of experience across preclinical and clinical research, including more than a decade leading Phase I to IV studies in oncology, rare diseases, and immunology, with direct experience in first-in-human and multicenter oncology trials. Claire is responsible for maintaining study quality through inspection readiness, corrective action planning, and proactive risk mitigation. She also oversees study budgets and vendor performance to support coordinated delivery across functions, drawing on a scientific foundation that includes a PhD in Neurosciences and Neuropharmacology. Based in Paris, France, Claire aligns scientific insight with operational execution to support successful trial outcomes., avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Claire%20Delaville.jpg',altText='Claire Delaville',fileId=214838927033}, lastname=Delaville, hs_initial_published_at=1781285742914, hs_created_by_user_id=26433386, hs_created_at=1781285678112, hs_is_edited=false, hs_deleted_at=0, name=Claire, job=Senior Project Manager, slug=claire-delaville, hs_updated_by_user_id=26433386}})

Deborah S.

Anthea G.

Claire D.

Discover

Clinical Trials

Early‑Phase Autoimmune Drug Development: Trial Design, Biomarkers and Statistical Strategies

Jun 03, ‘26 | 8 min read

Rui F Duarte-Lopes

Discover

Assays - Oncology

Case Study: Advancing IHC Assays from RUO to Clinical Trials and CDx

May 07, ‘26 | 8 min read

has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778874, hs_child_table_id=0, hs_updated_at=1765824406763, hs_published_at=1781285742914, description=Kennon Daniels is a scientific and regulatory in vitro diagnostic authority, specializing in the development of US regulatory strategies and FDA marketing submissions for IVD assays and instruments. Her expertise spans all aspects of product development, analytical and clinical trial protocol designs, Q-Submissions, IDEs, de novos, 510(k)s, and pre-market approval platforms., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Kennon%20Daniels.webp',altText='Kennon Daniels',fileId=165893120790}, linkedin=https://www.linkedin.com/in/kennon-daniels-ph-d-84a90b6, hs_name=, hs_path=, lastname=Daniels, PhD, hs_initial_published_at=1775839468505, hs_created_at=1709645745105, hs_is_edited=false, hs_deleted_at=0, name=Kennon, position=Vice President, IVD Regulatory Consulting, job=, slug=kennon-daniels, email=, hs_updated_by_user_id=26433386}, second={hs_id=164426546714, hs_child_table_id=0, hs_updated_at=1778171432595, hs_published_at=1781285742914, description=Angélique Heckmann, PhD is a people‑driven leader who combines scientific expertise and business acumen with a strong foundation in human values. With a background in therapeutic drug development and an MBA‑shaped strategic mindset, she focuses on building meaningful, long‑term relationships with teams, partners, and clients. By bridging science and strategy, she supports informed decision‑making, fosters collaboration, and helps translate innovation into real‑world impact—always guided by a shared purpose: advancing solutions that ultimately improve patients’ lives, avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/angelique-1.png',altText='angelique-1',fileId=194126030110}, lastname=Heckmann, PhD, hs_initial_published_at=1713174153602, hs_created_by_user_id=62155952, hs_created_at=1713172107894, hs_is_edited=false, hs_deleted_at=0, name=Angelique, job=Regional Vice President, Translational Business Solutions, slug=angelique-heckmann, hs_updated_by_user_id=26433386}, third={}})

Kennon D.
Angelique H.

Discover

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.

Discover Explore

Global CRO
Services

Award-winning CRO with deep oncology and rare disease expertise

Explore
Discover Explore

Global Laboratory
Services

Exceptional translational and biomarker sciences with global central lab services

Explore